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a b s t r a c t
INTRODUCTION: Pelvic exenteration (PE) is an ultra-radical surgical procedure characterized by the en
bloc resection of the pelvic organs.
METHODS: In this case series, we report retrospectively on four patients who underwent PE in Trinidad
and Tobago from 2012 to 2016. One male patient had rectal cancer while one each of three women had
cervical, colon, or rectal cancer.
RESULTS: Early postoperative complications (≤30 days) occurred in all patients, while late complications
(>30 days) occurred in one patient (Grade 1 – Clavien-Dindo classiﬁcation). Disease recurrence occurred
in 50% of patients, and the median overall survival was 8 months (range, 4–15 months).
DISCUSSION: There are many inherent challenges to conducting such major procedures in developing
countries, including inadequate blood product supplies, intensive care unit beds, and pre- and postoperative support services. With increased surgical capacity and support infrastructure, hospitals in these
regions would be equipped to perform PEs with better outcomes.
CONCLUSION: This case series adds to existing data on the feasibility of performing PE in developing
countries. We demonstrate that PE can be performed without major postoperative complications in a
resource-limited hospital. To the best of our knowledge, this is the ﬁrst case series that describes PE in
the Caribbean.
© 2017 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

1. Introduction
Pelvic exenteration (PE) is an ultra-radical surgical procedure
that was initially performed at the Ellis Fischel Cancer Center and
later described by Brunschwig in 1948 [1,2]. It is characterized by
the en bloc extirpation of the internal reproductive organs, pelvic
peritoneum, regional lymph nodes, anal canal, distal colon and
rectum, bladder, and inferior ureters. Pelvic exenteration is indicated in cases of persistent or recurrent malignancy in the pelvic
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region post chemoradiation, tumor conﬁnement to the central
pelvic region, and possible resectability to R0 margins.
Public exenteration is rarely performed in developing countries.
A literature search in PubMed/Medline and EMBASE databases
using the search topics “pelvic exenteration” and “Africa” and/or
“developing countries” and/or “Latin America” and/or “South
America” and/or “Central America” and/or “low income countries”
and/or “Caribbean” retrieved 16 citations. To the best of our knowledge, this is the ﬁrst case series that describes PEs in the Caribbean.
We report on all PEs carried out at the Eric Williams Medical
Sciences Complex (EWMSC), Champ Fleurs, Trinidad and Tobago
as performed by a single surgeon. This case report was prepared
according to the Process Guidelines, which provide a framework
for reporting surgical case series [3].

http://dx.doi.org/10.1016/j.ijscr.2017.03.006
2210-2612/© 2017 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).
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Table 1
Patient demographics.
Patient no.

Gender

Ancestry

Age (years)

BMI

Family history of
cancer

Alcohol/smoking
history

1

Female

Indian

45

13.7

None

2
3

Female
Male

African
Indian

52
51

31.6
16.9

Father: Throat CA,
Breast CA
Mother: Breast CA
None
None

4

Female

Indian

65

15.4

None

None
Smoker: 80 pack
years Alcohol:
Heavy
None

BMI, body mass index; CA, cancer.

Table 2
Preoperative indications.
Patient no.

Preoperative diagnosis

Preoperative
co-morbidities

Preoperative complications

Preoperative surgical history

nCRT

1

Uterine leiomyomata, locally
advanced stage 4 cervical CA
(left side ureter and
rectovaginal ﬁstula invasion)

Hypertension

Pelvic and rectal bleeding,
constipation, constant pain
(lower abdomen, lower back,
limbs), bilateral hand swelling,
persistent anemia, obstruction
of left nephrostomy tube due
to atrophic left kidney,
scoliosis, pelvic passage of
urine and stool

Myomectomy, partial
hysterectomy, radical total
abdominal hysterectomy with
bilateral
salpingo-oophorectomy, left
and right nephrostomy

6 weeks Taxol and
Gemcitabine, 6 weeks radiation

2

Colon CA eventually invading
the bladder

None

Severe constipation, abdominal
pain, infection post
colonoscopy

Partial colectomy

1 week chemotherapy, 1 week
radiation

3

Rectal CA eventually invading
the bladder, prostate, and right
hepatic lobe

Anemia

Change in bowel movements
associated with perineal pain,
tenesmus, melena,
constipation, post radiation
difﬁculty urinating

None

6 cycles Xelox and Avastin, 20
fractions radiation

4

Rectal CA stage IV with vaginal
invasion, rectovaginal ﬁstula

Type 2 diabetes
mellitus

Vaginal bleeding, constipation,
anemia

Hysterectomy and ileostomy

4 cycles chemotherapy, 1 cycle
radiation

nCRT, neoadjuvant chemoradiotherapy.

2. Materials and methods
This case series involved retrospective review of PE cases performed at a public tertiary teaching hospital in Trinidad and Tobago
from 2012 to 2016 by a single general surgeon with subspecialty
training in surgical oncology.
3. Results
Patient demographics, family history of cancer, behavioral characteristics, preoperative indications, and pre- and postoperative
complications are described in Table 1, Table 2, and Table 3 , respectively. Preoperative computed tomography (CT) images are shown
in Fig. 1. Elements of the operative procedure have been reported
previously [4] and will be brieﬂy reviewed here. In general, there
are three types of PEs: anterior exenteration, posterior exenteration, and total or radical exenteration. Each type is divided into
two phases: the exenterative phase, which aims to achieve clear
pathologic margins, and the reconstructive phase, which aims to
optimize functional outcomes by creating an ileal conduit, reinforcing the pelvic ﬂoor, and restoring bowel continuity. In each case,
the patient was placed in the lithotomy position and the abdomen
and perineum were cleaned and draped. Following a midline incision, the abdomen was opened in layers. A thorough exploration
of the peritoneal cavity and retroperitoneal spaces was executed,
including opening the retroperitoneal spaces and developing them
all the way to the pelvic ﬂoor. Next, the sigmoid colon and/or

ureters were completely mobilized and divided. Then, the organs to
be removed were mobilized. For anterior exenterations, these can
potentially include the bladder, vagina, uterus or prostate/seminal
vesicles, cervix, and adnexae. For posterior exenterations, these
can potentially include the rectosigmoid colon, vagina, uterus or
prostate/seminal vesicles, cervix, and adnexae. Finally, total or radical exenterations removed all of the listed tissues. The appropriate
organs were mobilized en-bloc by utilizing sharp and blunt dissection, clamp–cut–tie sequences, and/or electrosurgical devices
to address the relevant vascular supplies and suspensory attachments. After that, an elliptical perineal incision was made and
infralevator resection of the external genitalia and/or anus was
undertaken as indicated by disease extent. Individualized urinary
diversion and vaginal and/or perineal reconstruction were then
performed. To complete the procedure, a Jackson-Pratt closed suction drain was sutured in to the perineum. Selected intraoperative
and specimen images are shown in Fig. 2.
All four patients had a PE with colostomy, ileal conduit, urinary diversion, and R0 margins. Patients 1, 2, and 4 were N0, while
patient 3 was positive for lymph node metastasis. The postoperative complications graded by the Clavien-Dindo [5] classiﬁcation
and summarized in Table 3 show that none of the patients had
major complications (>grade 3) in the late postoperative period.
The long term oncologic outcomes are summarized in Table 4. With
a median follow-up of eight months (range 4–15 months), two
patients remain alive with no sign of recurrence.
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Table 3
Pre- and postoperative complications, according to Clavien-Dindo classiﬁcation.
Description of
complication A

Grade of
complication A
1 = Grade I
2 = Grade II
3 = Grade IIIa
4 = Grade IIIb
5 = Grade IVa
6 = Grade Ivb
7 = Grade V

Type of
postoperative
complication B
(>30 days after
surgery):
0 = No
complication
1 = Infection
2 = Fistula
3 = Bleeding/hematoma
4 = DGE/N&V
5 = Cardiopulmonary
6 = Liver
insufﬁciency
7 = Neurologic
8 = Pain
9 = Allergy
10 = Pancreatitis
11 = Other

Description
of
complication
B

Grade of
complication B
1 = Grade I
2 = Grade II
3 = Grade IIIa
4 = Grade IIIb
5 = Grade IVa
6 = Grade IVb
7 = Grade V

Grade of
highest
complication
1 = Grade I
2 = Grade II
3 = Grade IIIa
4 = Grade IIIb
5 = Grade IVa
6 = Grade IVb
7 = Grade V

Overall
total
number of
complications

1

1

UTI

1

1

Wound
infection

1

1

5

1

8

1

1

11

1

11

2

11

2

11

3

8

4

1

4

8

4

11

4

11

Pain in left leg
from stenosis
of left common
and external
iliac arteries
Wound
dehiscence
Decrease in
appetite
Wound
dehiscence
Decrease in
appetite
Pain at wound
site
Wound
infection
Pain at wound
site
Stoma
ischemia
Decrease in
appetite

4
1
4

0

2

0

1

1
1
1
1
4
1

DGE/N&V, delayed gastric emptying/nausea and vomiting; UTI, urinary tract infection.

4
0
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Type of
postoperative
complication A
(<30 days after
surgery):
0 = No
complication
1 = Infection
2 = Fistula
3 = Bleeding/hematoma
4 = DGE/N&V
5 = Cardiopulmonary
6 = Liver
insufﬁciency
7 = Neurologic
8 = Pain
9 = Allergy
10 = Pancreatitis
11 = Other
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Patient
number

Table 4
Intraoperative and postoperative features and outcomes.
Reconstruction
details

Operative
ﬁndings

Operative
time, min

Blood loss,
ml

Specimens
collected

Pathological
stage

PRM

Length of
postoperative
hospitalization

Evaluation 5
months
post-surgery

pCRT

Outcome

1

2016

Yes

PE, colostomy,
ileal conduit,
urinary
diversion

Adhesions,
frozen pelvis
with partial
radiation
changes,
rectovaginal
ﬁstula, gross
pelvic tumor
growth

720

400

Iliac lymph
node, colon
proximal
resection with
vascular
pedicle, anal
verge, rectum
with ﬁstula,
bladder with
urethra, vulva,
vagina

pT4N0M0

Negative

ICU (3 days),
surgical ward
(8 days), rehospitalization
(54 days)

Unavailable

None

Alive

2

2014

Yes

PE, colostomy,
ileal conduit,
urinary
diversion

600
Fumigating
necrotic mass
located 5 cm
from rectal
surgical
resection
margin,
extending into
urinary bladder
and vaginal
cuff

4000

pT3 b/c pNX
Section from
rectal end of
pM1.M1
surgical
resection
margin; 2nd
surgical
resection
margin, mass
in bowel,
ureters, urinary
bladder,
vaginal wall

Negative

90 days

Relief of
constipation
and pain,
psychological
relief, hopeful
for extended
life. Unable to
continue job
but able to
travel and live
independently.

Yes

Passed away
369 days post
PE of tumor
recurrence

3

2012

Yes

Anterior pelvic
exenteration,
ileal conduit,
urinary
diversion

601
Large rectal
tumor invading
bladder and
prostate;
nodules
palpated in
liver segments
3,6 7

2000

Left ureter,
right ureter,
distal sigmoid
colon, rectum,
anus, bladder,
prostate

Negative

9 days

Returned to job Yes
and
preoperative
QoL

Passed away
470 days post
PE of tumor
recurrence

4

2016

Yes

Posterior
exenteration,
colostomy, ileal
conduit,
urinary
diversion,
double-J stent
placement

Pelvic visceral
peritoneum,
abdominal
wall, ileum,
liver adhesions

200

Anus, sphincter pT4B pNX pM0
complex, lower
rectum,
posterior
vaginal wall,
caecum,
ascending
colon, distal
ileum

Negative

HDU (14 days),
surgical ward
(35 days)

Unavailable

451

pT4B

None

Alive

HDU, high dependency unit; ICU, intensive care unit; pCRT, post discharge chemoradiotherapy; PRM, pathological resection margin; QoL, quality of life.
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Fig. 1. Pre- and postoperative CT images. Red arrows indicate the regions invaded by the tumors. A1) Patient 1 preoperative, A2) Patient 1 postoperative, B1) Patient 2
preoperative, B2) Patient 2 postoperative, C1) Patient 3 preoperative, C2) Patient 3 postoperative, D1) Patient 4 preoperative, D2) Patient 4 postoperative.

Fig. 2. Intraoperative images. A) Patient 2, completed perineal dissection including urethra, vagina, and anus; B) Patient 2, perineum closed, suction drains placed; C) Patient
3, specimen following pelvic exenteration in a male patient, including rectum, anus, prostate, and bladder.

4. Discussion
Pelvic exenteration is the only potentially curative intervention for patients with advanced and recurrent pelvic cancers. In

this case series, we report on four patients who underwent PEs in
Trinidad and Tobago as performed by a single surgeon. Despite its
status as a high income country [6], there are challenges to performing this type of operation in Trinidad and Tobago given the

CASE REPORT – OPEN ACCESS
R. Maharaj et al. / International Journal of Surgery Case Reports 34 (2017) 4–10

absence of a surgical team dedicated to such procedures. In this
case series, a general surgeon with subspecialty training in surgical oncology led the operative teams. This surgeon performs a wide
range of procedures, ranging from general cases to intra-abdominal
and breast cancer surgeries. In contrast, high volume specialty hospitals typically employ a two-team approach to PEs, with one team
conducting the exenterative phase of the PE and a second team performing the reconstructive phase. When PEs are conducted by such
surgical teams in hospitals with specialty expertise, the operative
30-day mortality drops from 3.7 to 1.5% [7]. Other challenges to
conducting these radical surgeries in developing countries include
limited availability of blood products and intensive care unit beds.
In these settings, pre- and postoperative support services such as
physiotherapy, nutrition, and psychology are often stretched thin.
Additionally, PEs take more than 10 h on average, which increases
the waiting time for other surgical cases. Remarkably in this case
series, there were no peri- or postoperative mortalities during the
ﬁrst 12 months following surgery. Additionally, only three and zero
patients suffered major complications (grade 3 or above) in the
early and late postoperative periods, respectively.
In this series, only one patient was positive for lymph node
metastasis. The literature is inconclusive on the impact of tumorinvolved lymph nodes. Some case series have reported that lymph
node involvement was not predictive of survival [8,9], while others have reported that positive lymph nodes are associated with an
increased risk of recurrence and should be a contraindication for
PEs [10,11]. The literature is more deﬁnitive in relation to tumorinvolved margins as a poor prognostic indicator. In our series, all
of the patients had R0 resections. Given the poor prognosis associated with positive surgical margins after PE and the signiﬁcant
morbidity, even mortality, seen in conjunction with these procedures, it is generally accepted that ﬁxation of the tumor to the pelvic
side wall is a contraindication to PE [8]. The poor survival reported
by many case series points to the need for histopathologic review,
improved patient surveillance, and personalized chemoradiotherapy algorithms [8,12].
The optimal imaging modality when considering PE is positron
emission tomography/computed tomography (PET/CT). While
magnetic resonance imaging and stand-alone CT have demonstrated utility in mapping the pelvic tumor burden, PET/CT’s ability
to identify recurrent disease in patients with gynecologic malignancies and distinguish persistent or recurrent tumors from those
induced by post–PE radiotherapy renders it superior [13]. Currently, PET imaging units are not available in Trinidad and Tobago
or most developing countries, limiting a surgical teams’ ability to
assess tumor characteristics and determine patients’ eligibility for
PE. Accurate evaluation is critical for optimal patient selection.
Numerous studies have posited that careful selection of PE candidates may increase 5-year survival rates and patients’ quality of
life [14–16].
Given the high risk of operative-associated morbidity, special
attention to a holistic approach to postoperative management
should be considered in settings like Trinidad and Tobago where
many patients self-identify as being religious. It has been reported
that enhanced recovery from surgery and better pain management
is among the beneﬁts enjoyed by patients receiving postoperative compassionate support that serves the whole person: physical,
emotional, social, and spiritual [17]. Furthermore, the Joint Commission on Accreditation of Healthcare Organizations suggests that
pastoral care and other spiritual services are an integral part of
health care and that hospitals should provide pastoral care and
other spiritual services for patients who request them as part of
the recovery process [18].
Many patients struggle with psychological, social, and sexual
adjustments after undergoing PE [19]. To ameliorate this impact,
hospitals should consider offering the personalized service of a
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“care coach”. Ideally, this position would be held by a nurse
with specialties in psychiatry and oncology. Responsibilities could
include: inpatient and outpatient patient and family counselling
and education, proper stoma bag care, ensuring adequate home
preparations prior to discharge, scheduling follow-up clinic visits, and arranging social work appointments. Additionally, patient
navigators should be available to support the timely movement of
PE patients through the health care system [20]. Integrating these
services into a multi-disciplinary approach to PE clinical case management should contribute to lowered morbidity and improved
survival rates.
5. Conclusion
While the number of cases in our series limits survival statistics
assessment, we demonstrated that PEs can be performed safely in
a developing country with minimal complications. We believe that
increased surgical capacity, a multidisciplinary surgical board, rigorous patient selection, support services, thorough post-operative
management and overall technical capacity are necessary if these
operations are to become routine options in developing countries.
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